±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1091  |  »Ø¸´: 4
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

Èü¿ÆÒ×Ò½Ò©

гæ (³õÈëÎÄ̳)

[½»Á÷] ÁÙ´²Ñо¿¼à²éÔ±/CRA/SCRAclinical research associate

¾ßÌ幤×÷µØµã:
±±¾©
н½ð:
ÃæÒé
ѧÀúºÍÑо¿·½Ïò:
Ò½Ò©Ñз¢
ÕÐÆ¸¸Úλ:
ÁÙ´²¼à²éÔ±
¹«Ë¾Ãû³Æ:
±±¾©Èü¿ÆÒ×Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
¹«Ë¾ÍøÖ·:
www.sqe-pharma.com
ÁªÏµ·½Ê½:
010-63103427

¹¤×÷Ö°Ôð
1£¬°´ÕÕ·½°¸¡¢GCPºÍSOP£¬Æô¶¯¡¢¼à²éºÍ¹Ø±ÕÁÙ´²ÊÔÑ飻
2£¬¹ÜÀíÑо¿ÖÐÐÄ£»
3£¬ºÍÑо¿ÖÐÐı£³ÖÁ¼ºÃÓÐЧµÄ¹µÍ¨£»
4£¬¼°Ê±ÕýÈ·µØ±¨¸æËùÓв»Á¼Ê¼þ£»
5£¬×éÖ¯ÕÙ¿ªÁÙ´²ÊÔÑé»áÒ飻
6£¬ÅàѵÑо¿ÖÐÐÄÈËÔ±£»

ְλҪÇó£º
1£¬Ò½Ò©Ïà¹Ø×¨Òµ±¾¿Æ¼°ÒÔÉÏ£»
2£¬ÖÁÉÙ1ÄêÁÙ´²ÊÔÑéÏà¹Ø¾­Ñ飻
3£¬Á¼ºÃµÄÓ¢ÓïºÍ¼ÆËã»úˮƽ£»
4£¬Á¼ºÃµÄ¹µÍ¨ÄÜÁ¦ºÍÎÊÌâ´¦ÀíÄÜÁ¦£»
5£¬Á¼ºÃµÄÍŶӺÏ×÷¾«Éñ£»
Responsibility:
-To initiate, monitor and close clinical trials in compliance with study protocol, GCP & SOPs.
-To help managing & resolving study related issues at sites.
-To develop and maintain good and effective communication with clinical research staff.
-To report all Adverse Events timely and properly.
-To organize investigator meetings.
-To provide on-site training.

Qualification:
-Medical or Pharmacological BS,or higher degree.
-At least 1 year relevant working experience.
-Skilled at English & computer.
-Good communication and analytical skill.
-Team player.
ÓÐÒâÕßÇ뽫¼òÀú·¢Ë͵½ÓÊÏ䣺hr@sqe-pharma.com
ÁªÏµÈË£ºÎâŮʿ

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Èü¿ÆÒ×Ò½Ò©

гæ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by °ÍÀ²À² at 2012-05-24 14:46:41:
¶¥Ò»Ï£¬Ó¦½ìÉú¿¼ÂÇÂð

¿ÉÏÈ·¢¼òÀú¿´Ò»ÏÂ
3Â¥2012-05-24 15:42:54
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 5 ¸ö»Ø´ð

°ÍÀ²À²

гæ (СÓÐÃûÆø)

¶¥Ò»Ï£¬Ó¦½ìÉú¿¼ÂÇÂð
2Â¥2012-05-24 14:46:41
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hongfeng667

ľ³æ (ÕýʽдÊÖ)

±¾¿Æ£¬ÈýÄêÑз¢¾­Ñ飬ÓÐGCPÅàѵ֤Ê飬ûCRA¾­Ñ飬ÐÐÂð
4Â¥2012-06-08 15:55:54
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÕÅѧÓñ

½ð³æ (СÓÐÃûÆø)

ûÓÐÁÙ´²ÊµÑé¾­Ñé¿ÉÒÔ·Å¿íµãÂð£¿
5Â¥2012-06-13 14:52:56
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á +17 µ¾ÆÞС±à 2026-03-26 17/850 2026-03-29 19:07 by ѧԱ8dgXkO
[¿¼ÑÐ] ¿¼Ñе÷¼Á +7 СÀ¯ÐÂ±Ê 2026-03-29 7/350 2026-03-29 19:00 by ѧԱ8dgXkO
[¿¼ÑÐ] »·¾³¹¤³Ì 085701£¬267Çóµ÷¼Á +6 minht 2026-03-29 6/300 2026-03-29 16:21 by ѧԱ8dgXkO
[¿¼ÑÐ] Çóµ÷¼Á +9 ÕÅzz111 2026-03-27 10/500 2026-03-29 14:57 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£ÖÝ´óѧ£¬080500ѧ˶£¬×Ü·Ö317·ÖÇóµ÷¼Á +8 ¾Ù¸öÀõ×Óoi 2026-03-24 9/450 2026-03-29 13:08 by peike
[¿¼ÑÐ] 085701»·¾³¹¤³Ì£¬267Çóµ÷¼Á +16 minht 2026-03-26 16/800 2026-03-28 12:16 by zllcz
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +7 hanamiko 2026-03-27 7/350 2026-03-28 09:56 by ÀîÉϰ¶0921
[¿¼ÑÐ] 081200-314 +3 LILIQQ 2026-03-27 4/200 2026-03-28 09:41 by ±£»¤µØÇòÄãÎÒ×öÆ
[²ÄÁϹ¤³Ì] Ò»Ö¾Ô¸C9²ÄÁÏÓ뻯¹¤×¨Òµ×Ü·Ö300Çóµ÷¼Á +8 Âü111 2026-03-24 9/450 2026-03-28 07:58 by YYYYX1234
[¿¼ÑÐ] 308Çóµ÷¼Á +7 īīĮ 2026-03-27 7/350 2026-03-28 07:43 by ÈÈÇéɳĮ
[¿¼ÑÐ] 348Çóµ÷¼Á +4 СÀÁ³æ²»ÀÁÁË 2026-03-27 5/250 2026-03-27 12:47 by ¹û¹ûÂèßä
[¿¼ÑÐ] 333Çóµ÷¼Á +3 questionÍì·ç 2026-03-23 3/150 2026-03-27 11:29 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 359Çóµ÷¼Á +4 ÍõÁ˸öéª 2026-03-25 4/200 2026-03-27 08:43 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] µ÷¼ÁÇóÊÕÁô +7 ¹ûÈ»ÓÐÎÒ 2026-03-26 7/350 2026-03-27 00:26 by wxiongid
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©Óʵç´óѧ 288·Ö ²ÄÁÏ¿¼ÑÐ Çóµ÷¼Á +3 jl0720 2026-03-26 3/150 2026-03-26 13:39 by zzll406
[¿¼ÑÐ] ´ò¹ýºÜ¶à¾ºÈü£¬085406¿ØÖƹ¤³Ì300·Ö£¬Çóµ÷¼Á +3 askeladz 2026-03-26 3/150 2026-03-26 09:08 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] ²ÄÁÏר˶ 335 ·ÖÇóµ÷¼Á +4 ¾Ü¾øÀ䱩Á¦ 2026-03-25 4/200 2026-03-25 18:45 by haxia
[¿¼ÑÐ] 285Çóµ÷¼Á +3 AZMK 2026-03-24 3/150 2026-03-25 12:23 by userper
[¿¼ÑÐ] 080500Çóµ÷¼Á +3 zzzzfan 2026-03-24 3/150 2026-03-24 16:38 by barlinike
[¿¼ÑÐ] 335Çóµ÷¼Á +4 yuyuÓî 2026-03-23 5/250 2026-03-23 23:49 by Txy@872106
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û